Responsiveness And Minimal Clinically Important Difference Of Navicular Height Drop Test With Plantar Fasciitis
1 other identifier
observational
40
1 country
1
Brief Summary
Plantar fasciitis is a common musculoskeletal condition characterized by heel pain and impaired foot function, often linked to abnormal foot biomechanics. The Navicular Height Drop (NHD) test is a non-invasive tool used to assess dynamic foot posture by measuring changes in the medial longitudinal arch. Evaluating the test's responsiveness and minimal clinically important difference (MCID) can help determine its clinical relevance in monitoring treatment outcomes. Study objective to evaluate the responsiveness and determine the minimal clinically important difference (MCID) of the Navicular Height Drop (NHD) test in patients with plantar fasciitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2025
CompletedFirst Submitted
Initial submission to the registry
June 28, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJuly 9, 2025
June 1, 2025
6 months
June 28, 2025
June 28, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Navicular Height Drop Test (NHDT)
This test measures the change in the position of the navicular bone during weight-bearing, helping to assess foot arch collapse and the impact of abnormal foot biomechanics, which is crucial in conditions like plantar fasciitis
12 Months
GLOBAL RATING OF CHANGE (GRC)
The GRC scale is a simple tool where patients rate their overall improvement after treatment. It is often used to establish the MCID by comparing patients' subjective perceptions of improvement with changes in objective measures like NHDT. The responses are usually rated on a Likert-type scale, which might look like this:+7: Very Much Improved ,+6: Much Improved ,+5: Improved ,+4: Minimally Improved ,+3: No Change ,+2: Minimally Worse ,+1: Worse ,0: Very Much Worse(31).
12 Months
Foot Function Index
A self-reported questionnaire assessing pain, disability, and activity limitation in individuals with foot disorders, commonly used to assess the functional impact of plantar fasciitis.
12 Months
Interventions
Evaluating the test's responsiveness and minimal clinically important difference (MCID) can help determine its clinical relevance in monitoring treatment outcomes.
Eligibility Criteria
A Perspective Cohort Study. This study aims to establish the responsiveness and MCID of the NHD test, enabling its effective use as a clinical tool for monitoring plantar fasciitis outcomes. By identifying clinically meaningful changes
You may qualify if:
- Patients with a clinical diagnosis of Plantar Fasciitis confirmed by Orthopedic presence of heel pain, particularly at the plantar aspect of the heel, for more than 3 months.
- Pain on palpation of the medial calcaneal tubercle.
- Positive Windlass test.
- Adults aged 25-60 years.
- Patients should be able to perform the Navicular Drop Test without any other concurrent - lower limb pathology that might interfere with the test (e.g., Achilles tendonitis, knee osteoarthritis, etc.).
You may not qualify if:
- Patients who have undergone any surgical intervention in the foot or ankle (e.g., plantar fascia release, foot fracture surgery).
- Recent history (within 6 weeks) of acute foot or ankle injury (e.g., fractures, sprains).
- Conditions such as rheumatoid arthritis, diabetes, neuropathy, peripheral vascular disease, or any neurological disorders affecting the lower limbs that could confound the results.
- Patients with other foot conditions like flatfoot deformity, bunion deformity, Morton's neuroma, severe hallux valgus, or any other condition affecting foot biomechanics that might alter the Navicular Drop Test results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Omer Hospital & Cardiac Center
Lahore, Punjab Province, Pakistan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 28, 2025
First Posted
July 9, 2025
Study Start
March 17, 2025
Primary Completion
September 1, 2025
Study Completion
February 28, 2026
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share